Cargando…

EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53

Posttransplant lymphoproliferative disorders (PTLDs) are a diverse group of lymphoid or plasmacytic proliferations frequently driven by Epstein-Barr virus (EBV). EBV-negative PTLDs appear to represent a distinct entity. This report describes an unusual case of a 33-year-old woman that developed a mo...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bogusz, Agata M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402239/ https://www.ncbi.nlm.nih.gov/pubmed/28487787 http://dx.doi.org/10.1155/2017/5083463

Ejemplares similares

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Fatal Case of EBV-negative Posttransplant Lymphoproliferative Disorder With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient
por: Mazzola Poli de Figueiredo, Sergio, et al.
Publicado: (2022)

Clinical Characteristics of Monomorphic Post-transplant Lymphoproliferative Disorders
por: Choi, Jung-Hye, et al.
Publicado: (2010)

Posttransplant lymphoproliferative disease presenting as jejunal perforation
por: Krishna, K. C., et al.
Publicado: (2009)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
por: Neuringer, Isabel P.
Publicado: (2013)

Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass
por: Arasaratnam, Reuben J., et al.
Publicado: (2017)

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
por: Afiat, Thanh-Phuong, et al.
Publicado: (2018)

Plasmacytoma/multiple myeloma type posttransplant lymphoproliferative disorder
por: Claushuis, Theodora A.M., et al.
Publicado: (2022)

Monomorphic post-transplant lymphoproliferative disorder of the tongue: case report and review of literature
por: Gonzalez-Cuyar, Luis F, et al.
Publicado: (2007)

Hematopoietic Stem Cell Transplantation after Posttransplant Lymphoproliferative Disorder
por: Kim, Min Joo, et al.
Publicado: (2010)

Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
por: Mynarek, Martin, et al.
Publicado: (2013)

Isolated Upper Extremity Posttransplant Lymphoproliferative Disorder in a Child
por: Halula, Sarah E., et al.
Publicado: (2015)

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
por: Dharnidharka, Vikas R., et al.
Publicado: (2019)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
por: Schultze-Florey, Rebecca E., et al.
Publicado: (2018)

P1560: EARLY DIAGNOSIS WITH EBV MONITOR AND PREEMPTIVE RITUXIMAB REDUCES POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER MORTALITY AND INCREASE OVERALL SURVIVAL AFTER ALLOGENEIC TRANSPLANTATION
por: Liu, Jia-Hau, et al.
Publicado: (2023)

Thymic Hyperplasia after Lung Transplantation Imitating Posttransplant Lymphoproliferative Disorder
por: Steger, Christina Maria, et al.
Publicado: (2011)

Postrenal Transplant Metastatic Colonic Neoplasm: Posttransplant Lymphoproliferative Disorder or Adenocarcinoma?
por: Lal, H., et al.
Publicado: (2017)

Recurrent, Multisubtype Posttransplant Lymphoproliferative Disorder Masquerading as Inflammatory Bowel Disease
por: Mussarat, Saad, et al.
Publicado: (2022)

Bone marrow involvement by classic Hodgkin lymphoma posttransplant lymphoproliferative disorder
por: Lyapichev, Kirill A., et al.
Publicado: (2021)

Editorial: Infections and posttransplant lymphoproliferative disease after pediatric kidney transplantation
por: Kizilbash, Sarah J., et al.
Publicado: (2023)

ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia
por: Menezes, J, et al.
Publicado: (2013)

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes
por: Devillier, Raynier, et al.
Publicado: (2015)

Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022)

ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells
por: Inoue, Daichi, et al.
Publicado: (2018)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
por: Malhotra, Bharat, et al.
Publicado: (2015)

Posttransplant Lymphoproliferative Disorder Isolated to the Adrenal Gland in a Liver Transplant Patient
por: Ghaziani, Tara T., et al.
Publicado: (2018)

Posttransplant Lymphoproliferative Disorder in a Patient with Worsening Ascites after Liver Transplantation
por: Patel, Harsh D., et al.
Publicado: (2017)

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
por: Hong, Mineui, et al.
Publicado: (2013)

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Successful Treatment of Posttransplant EBV-Associated Lymphoma and Plasmacytoma Solely Localized to the CNS
por: Hansen, Per Boye, et al.
Publicado: (2012)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
por: Twist, Clare J., et al.
Publicado: (2013)

Plasmacytoma-Like Posttransplant Lymphoproliferative Disease in a Disused Arteriovenous Fistula: The Importance of Histopathology
por: Kousios, Andreas, et al.
Publicado: (2019)

Posttransplant Lymphoproliferative Disorder: Experience from a Pediatric Nephrology Unit in North India
por: Thergaonkar, R. W., et al.
Publicado: (2018)

HLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort
por: Vase, Maja Ølholm, et al.
Publicado: (2015)

Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: report from a single center
por: Muti, G., et al.
Publicado: (2000)

Late-Onset Posttransplant Lymphoproliferative Disorder Results in Jejunal Stricture Managed with Endoscopic Dilation
por: Park, Steven, et al.
Publicado: (2021)

Spontaneous regression of central nervous system posttransplant lymphoproliferative disease: A case report
por: Gao, Rupan, et al.
Publicado: (2021)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

BCOR involvement in cancer
por: Astolfi, Annalisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cki51f1tvdvplmq49d3463p3n4